BCL2L11 and neoplasm: This review systematically elucidates the expression profiles, signaling pathways, and the immune checkpoint molecule regulatory mechanisms localized on the NK cell membrane (e.g., NKG2A, KIRs, and TIGIT) or intracellularly (e.g., BIM, Cbl-b, and EZH2) during tumor immune evasion.